Dinarello CA - Search Results

1

Phase I trial of interleukin 2 in combination with the soluble tumor necrosis factor receptor p75 IgG chimera.

Trehu EG, Mier JW, Dubois JS, Sorce D, Klempner MS, Epstein M, Dinarello CA, Shapiro L, Kappler K, Ronayne L, Atkins MB. Trehu EG, et al. Among authors: dinarello ca. Clin Cancer Res. 1996 Aug;2(8):1341-51. Clin Cancer Res. 1996. PMID: 9816306 Clinical Trial.

2

Induction of circulating tumor necrosis factor (TNF alpha) as the mechanism for the febrile response to interleukin-2 (IL-2) in cancer patients.

Mier JW, Vachino G, van der Meer JW, Numerof RP, Adams S, Cannon JG, Bernheim HA, Atkins MB, Parkinson DR, Dinarello CA. Mier JW, et al. Among authors: dinarello ca. J Clin Immunol. 1988 Nov;8(6):426-36. doi: 10.1007/BF00916947. J Clin Immunol. 1988. PMID: 3265420

3

Induction of circulating soluble tumour necrosis factor receptor and interleukin 1 receptor antagonist following interleukin 1 alpha infusion in humans.

Tilg H, Trehu E, Shapiro L, Pape D, Atkins MB, Dinarello CA, Mier JW. Tilg H, et al. Among authors: dinarello ca. Cytokine. 1994 Mar;6(2):215-9. doi: 10.1016/1043-4666(94)90044-2. Cytokine. 1994. PMID: 8032003 Clinical Trial.

4

Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55.

Tilg H, Trehu E, Atkins MB, Dinarello CA, Mier JW. Tilg H, et al. Among authors: dinarello ca. Blood. 1994 Jan 1;83(1):113-8. Blood. 1994. PMID: 8274730 Free article. Clinical Trial.

5

Induction of circulating and erythrocyte-bound IL-8 by IL-2 immunotherapy and suppression of its in vitro production by IL-1 receptor antagonist and soluble tumor necrosis factor receptor (p75) chimera.

Tilg H, Shapiro L, Atkins MB, Dinarello CA, Mier JW. Tilg H, et al. Among authors: dinarello ca. J Immunol. 1993 Sep 15;151(6):3299-307. J Immunol. 1993. PMID: 8397255

6

Pro-interleukin-1 beta production by a subpopulation of human T cells, but not NK cells, in response to interleukin-2.

Numerof RP, Kotik AN, Dinarello CA, Mier JW. Numerof RP, et al. Among authors: dinarello ca. Cell Immunol. 1990 Oct 1;130(1):118-28. doi: 10.1016/0008-8749(90)90166-o. Cell Immunol. 1990. PMID: 2144468

7

Antiinflammatory properties of hepatic acute phase proteins: preferential induction of interleukin 1 (IL-1) receptor antagonist over IL-1 beta synthesis by human peripheral blood mononuclear cells.

Tilg H, Vannier E, Vachino G, Dinarello CA, Mier JW. Tilg H, et al. Among authors: dinarello ca. J Exp Med. 1993 Nov 1;178(5):1629-36. doi: 10.1084/jem.178.5.1629. J Exp Med. 1993. PMID: 7693853 Free PMC article.

8

Ciliary neurotrophic factor combined with soluble receptor inhibits synthesis of proinflammatory cytokines and prostaglandin-E2 in vitro.

Shapiro L, Panayotatos N, Meydani SN, Wu D, Dinarello CA. Shapiro L, et al. Among authors: dinarello ca. Exp Cell Res. 1994 Nov;215(1):51-6. doi: 10.1006/excr.1994.1313. Exp Cell Res. 1994. PMID: 7957680

9

Induction of circulating antagonists to IL-1 and TNF by IL-2 administration and their effects on IL-2 induced cytokine production in vitro.

Tilg H, Shapiro L, Vannier E, Poutsiaka DD, Trehu E, Atkins MB, Dinarello CA, Mier JW. Tilg H, et al. Among authors: dinarello ca. J Immunol. 1994 Mar 15;152(6):3189-98. J Immunol. 1994. PMID: 8144913

10

Circulating interleukin-1 and tumor necrosis factor antagonists in liver disease.

Tilg H, Vogel W, Wiedermann CJ, Shapiro L, Herold M, Judmaier G, Dinarello CA. Tilg H, et al. Among authors: dinarello ca. Hepatology. 1993 Nov;18(5):1132-8. Hepatology. 1993. PMID: 8225219

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,093 results

Search Page

Filters